Company Filing History:
Years Active: 2022
Title: Debasis Mondal: Innovator in HIV Treatment
Introduction
Debasis Mondal is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of medical science, particularly in the treatment of HIV. His innovative approach utilizes mesenchymal stem cells to combat the virus effectively.
Latest Patents
Debasis Mondal holds 1 patent for his work titled "Expression of HIV inhibitors by mesenchymal stem cells." This patent discloses a composition of matter and method for treating HIV using mesenchymal stem cells (MSC). Specifically, the MSCs are transduced with vectors that incorporate an anti-viral fusion inhibitor, such as a C46-derived peptide or neutralizing antibody. The transduced MSCs are capable of expressing the inhibitor and preventing HIV virus-cell fusion.
Career Highlights
Throughout his career, Debasis Mondal has worked with esteemed institutions, including the Administrators of the Tulane Educational Fund and Tulane University. His work has been pivotal in advancing research in HIV treatment.
Collaborations
Debasis has collaborated with notable professionals in his field, including Stephen E. Braun and Bruce Alan Bunnell. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Debasis Mondal's work in the field of HIV treatment showcases his dedication to medical innovation. His patent on the use of mesenchymal stem cells represents a significant advancement in the fight against HIV.